DAA269 |
alpha-kinase 2 |
ALPK2 |
20.0% Increase Gene Expression Level |
kidney |
Human |
|
DAA475 |
alpha-kinase 3 |
ALPK3 |
6.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA235 |
transgelin 3 |
TAGLN3 |
5.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA347 |
aminolevulinate, delta-, synthase 1 |
ALAS1 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2394 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
17.8% Decrease DNA Methylation |
dermis |
Human |
|
DAA2395 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
20.1% Decrease DNA Methylation |
dermis |
Human |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
15.1% Decrease DNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
20.1% Decrease DNA Methylation |
mesenchymal stem cell |
Human |
|
DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
APBB1IP |
23.0% Increase Gene Expression Level |
kidney |
Human |
|
DAA2100 |
anaphase promoting complex subunit 4 decreases with age |
ANAPC4 |
35.5% Decrease Gene Expression Level |
ovary |
Human |
|
DAA2119 |
angel homolog 2 (Drosophila) decreases with age |
ANGEL2 |
65.3% Decrease Gene Expression Level |
ovary |
Human |
|
DAA8 |
angiomotin |
AMOT |
10.0% Increase Gene Expression Level |
brain |
Human |
|
DAA9 |
ankyrin 2, neuronal |
ANK2 |
20.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA11 |
annexin A4 |
ANXA4 |
11.0% Increase Gene Expression Level |
brain |
Human |
|
DAA22 |
antizyme inhibitor 1 |
AZIN1 |
11.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA1223 |
APOE promoter methylation decrease |
APOE |
— |
prefrontal cortex |
Human |
|
DAA13 |
apolipoprotein D |
APOD |
14.0% Increase Gene Expression Level |
brain |
Human |
|
DAA373 |
apolipoprotein O |
APOO |
5.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2111 |
arginyl-tRNA synthetase 2, mitochondrial decreases with age |
RARS2 |
48.7% Decrease Gene Expression Level |
ovary |
Human |
|
DAA1202 |
arNOX specific activity increases |
ENOX1 |
— |
skin |
Human |
|
DAA306 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
ASNA1 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2088 |
aryl-hydrocarbon receptor repressor; programmed cell death 6 decreases with age |
PDCD6 |
60.9% Decrease Gene Expression Level |
ovary |
Human |
|
DAA14 |
arylsulfatase A |
ARSA |
17.0% Increase Gene Expression Level |
brain |
Human |
|
DAA2413 |
Arylsulfatase G increases with age |
ARSG |
19.6% Increase DNA Methylation |
dermis |
Human |
|
DAA318 |
5'-3' exoribonuclease 1 |
ERI1 |
4.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|